Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Simvastatin is a medication used in this trial to see if it can help prevent new episodes of recurrent pancreatitis . It is commonly used to lower cholesterol and reduce the risk of heart disease, but in this study , researchers are investigating whether it can also reduce the frequency of pancreatitis attacks.

In conclusion, the SIMBA study is a researcher-driven triple-blind randomized placebo-controlled, parallel-group, multicenter trial aiming to compare recurrence of new episodes of pancreatitis in patients with recurrent AP or acute flares of CP, consuming simvastatin vs. placebo.
Study Details

The main aim of SIMBA ( SIMvastatin in the prevention of recurrent pancreatitis , a triple Blind rAndomized controlled multicenter trial) is to compare the recurrence rate of pancreatitis in patients with established recurrent pancreatitis (acute pancreatitis and acute flares in chronic pancreatitis ) consuming simvastatin versus placebo.
Methods: The SIMBA study is a triple-blind randomized placebo-controlled, parallel-group multicenter trial. Patients with recurrent AP or with acute flares of CP (at least two episodes in the last 12 months) will be randomized to receive simvastatin 40 mg daily or placebo.

Simvastatin in the Prevention of Recurrent Pancreatitis
In conclusion, the SIMBA study is a researcher-driven triple-blind randomized placebo-controlled, parallel-group, multicenter trial aiming to compare recurrence of new episodes of pancreatitis in patients with recurrent AP or acute flares of CP, consuming simvastatin vs. placebo.
Conclusion This trial, evaluating simvastatin versus placebo for the prevention of pancreatitis , did not demonstrate a reduction in recurrence rate, although results might be underpowered due to early termination. The relationship between statins in these patients and new-onset diabetes requires further investigation.

Simvastatin in the prevention of recurrent pancreatitis
Simvastatin in the prevention of recurrent pancreatitis : a triple-blinded randomised clinical trial (the SIMBA trial)
262 SIMVASTATIN IN THE PREVENTION OF RECURRENT PANCREATITIS : A TRIPLE-BLINDED RANDOMIZED CLINICAL TRIAL (THE SIMBA TRIAL)

Simvastatin in the Prevention of Recurrent Pancreatitis (SIMBA
Recurrent acute pancreatitis and recurrent relapses of inflammation in chronic pancreatitis are an important problem. In some cases, prevention of these acute flares of inflammation is not possible. Population-based studies and meta-analysis of randomized controlled trials suggest that statins may decrease the incidence of acute pancreatitis .







About Recurrent acute pancreatitis and recurrent relapses of inflammation in chronic pancreatitis are an important problem. In some cases, prevention of these acute flares of inflammation is not possible. Population-based studies and meta-analysis of randomized controlled trials suggest that statins may decrease the incidence of acute pancreatitis . SIMBA aims to investigate the effect of ...